Virtual Posters & Abstracts

Thank you for considering sharing your hematologic malignancies research outcomes with the healthcare community at the 2023 Lymphoma, Leukemia & Myeloma Congress. 

• Increase Your Research Engagement. Seize the opportunity to present your work to more than 1,000+ attendees at one of the most respected forums for industry-leading hematologic research and clinical case studies.
• Get Published. Accepted abstracts will be published in the American Journal of Hematology and shared on the Oncology Learning Network.
• Receive Accolades. Each year the Congress Chairs recognize the “Best Of” submitted abstracts. Winning abstracts receive free congress registration.

Accepted abstracts will be published in the American Journal of Hematology and shared with attendees as digital posters accessible online. Only abstracts received by the submission deadline will be published.

Important Abstract Dates
 

Abstracts will be accepted in the following categories: Acute Leukemia & Myeloproliferative/Myelodysplastic Diseases, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Lymphoma. 

Acute Leukemia & Myeloproliferative/Myelodysplatic Diseases  

A1. Clinical Trials
A2. Procedures and Diagnostics
A3. Epidemiology and Outcomes Research
A4. Clinical Case Reports
 

Multiple Myeloma

M1. Clinical Trials
M2. Procedures and Diagnostics
M3. Epidemiology and Outcomes Research
M4. Clinical Case Reports
 

Chronic Lymphocytic Leukemia

C1. Clinical Trials
C2. Procedures and Diagnostics
C3. Epidemiology and Outcomes Research
C4. Clinical Case Reports
 

Lymphoma

L1. Clinical Trials
L2. Procedures and Diagnostics
L3. Epidemiology and Outcomes Research
L4. Clinical Case Reports
 

Clinical Trials in Progress*

L1. Trials in Progress in Leukemia
L2. Trials in Progress in Lymphoma
L3. Trials in Progress in Myeloma
L4. Trials in Progress in CLL

* Please submit all trials in progress in this category